Listed

Mesa Laboratories Inc: Form 10-Q for the period ended Dec 31, 2013

Filed with the SEC on Feb 5, 2014 and accepted by EDGAR at Feb 5, 2014, 10:00 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2013-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2013-10-01 to 2013-12-31$13.1mus-gaap:SalesRevenueNet
Revenue9 months2013-04-01 to 2013-12-31$37.0mus-gaap:SalesRevenueNet
Gross profit3 months2013-10-01 to 2013-12-31$7.7mus-gaap:GrossProfit
Gross profit9 months2013-04-01 to 2013-12-31$22.1mus-gaap:GrossProfit
Research and development3 months2013-10-01 to 2013-12-31$524.0kus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2013-04-01 to 2013-12-31$1.6mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2013-10-01 to 2013-12-31$2.8mus-gaap:OperatingIncomeLoss
Operating income9 months2013-04-01 to 2013-12-31$8.4mus-gaap:OperatingIncomeLoss
Income tax3 months2013-10-01 to 2013-12-31$981.0kus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2013-04-01 to 2013-12-31$3.1mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2013-10-01 to 2013-12-31$1.7mus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Net income9 months2013-04-01 to 2013-12-31$5.5mus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Diluted EPS3 months2013-10-01 to 2013-12-31$0.48us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2013-04-01 to 2013-12-31$1.54us-gaap:EarningsPerShareDiluted
Basic EPS3 months2013-10-01 to 2013-12-31$0.51us-gaap:EarningsPerShareBasic
Basic EPS9 months2013-04-01 to 2013-12-31$1.62us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2013-10-01 to 2013-12-313,637,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2013-04-01 to 2013-12-313,591,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2013-04-01 to 2013-12-31$9.5mus-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Dividends paid9 months2013-04-01 to 2013-12-31$1.5mus-gaap:PaymentsOfDividendsCommonStock
Share repurchases9 months2013-04-01 to 2013-12-31$15.0kus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2013-12-31$2.2mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2013-12-31$20.6mus-gaap:AssetsCurrent
Total assetsAt period end2013-12-31$92.6mus-gaap:Assets
Current liabilitiesAt period end2013-12-31$10.8mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2013-12-31$34.0mus-gaap:Liabilities
Long-term debtAt period end2013-12-31$16.0mus-gaap:LongTermDebtNoncurrent
Shareholders' equityAt period end2013-12-31$58.5mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001104659-14-006596. Last ingested by Listed: Nov 13, 2026, 07:45 ET. Listed shows no prices and gives no investment advice.